Cutia Therapeutics

HKSE:02487 (China)  
HK$ 6.62 (-1.91%) Dec 24
At Loss
P/B:
1.58
Market Cap:
HK$ 2.05B ($ 260.69M)
Enterprise V:
HK$ 1.26B ($ 260.69M)
Volume:
981.00K
Avg Vol (2M):
825.97K
Trade In:
Volume:
981.00K
At Loss
Avg Vol (2M):
825.97K

Business Description

Description
Cutia Therapeutics is a dermatology-focused biopharmaceutical company focused on the broader dermatology treatment and care therapeutic areas, including localized adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia. Its core product is CU-20401, which is a recombinant mutant collagenase that targets obesity, overweight, or other localized adipose accumulation-associated metabolic diseases. Its other products include CU-40102 (topical finasteride spray); CU-10201; CU-40101; and CU-10101 (topical novel small molecule agent) among others. Geographically, the company generates its revenue from the People's Republic of China.
Name Current Vs Industry Vs History
Cash-To-Debt 3.94
Equity-to-Asset 0.79
Debt-to-Equity 0.22
Debt-to-EBITDA -0.55
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.21
Distress
Grey
Safe
Beneish M-Score 5.36
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y EPS without NRI Growth Rate 58.52
Future 3-5Y Total Revenue Growth Rate 83.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 5.1
9-Day RSI 9.19
14-Day RSI 15.23
6-1 Month Momentum % 44.29
12-1 Month Momentum % -14.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.09
Quick Ratio 4.82
Cash Ratio 4.37
Days Inventory 161.25
Days Sales Outstanding 73.19
Days Payable 31.16

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -8.94

Financials

HKSE:02487's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cutia Therapeutics Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 215.856
EPS (TTM) (HK$) -1.875
Beta 0
Volatility % 105.72
14-Day RSI 15.23
14-Day ATR (HK$) 0.422464
20-Day SMA (HK$) 7.3485
12-1 Month Momentum % -14.9
52-Week Range (HK$) 5.57 - 18.26
Shares Outstanding (Mil) 305.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cutia Therapeutics Filings

Filing Date Document Date Form
No Filing Data

Cutia Therapeutics Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

Cutia Therapeutics Frequently Asked Questions

What is Cutia Therapeutics(HKSE:02487)'s stock price today?
The current price of HKSE:02487 is HK$6.62. The 52 week high of HKSE:02487 is HK$18.26 and 52 week low is HK$5.57.
When is next earnings date of Cutia Therapeutics(HKSE:02487)?
The next earnings date of Cutia Therapeutics(HKSE:02487) is .
Does Cutia Therapeutics(HKSE:02487) pay dividends? If so, how much?
Cutia Therapeutics(HKSE:02487) does not pay dividend.

Press Release

Subject Date
No Press Release